Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Carson

Showing results (691-700 of 918) with videos related to

Pageof 92
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2016
Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A EnzymeLaigao Chen, Nabeel Nabulsi, Mika Naganawa, et al.
Annals of Neurology|December 14, 2011
Recovery from chronic spinal cord contusion after Nogo receptor interventionXingxing Wang, Philip Duffy, Aaron W McGee, et al.
Psychopharmacology|August 16, 2016
Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNORagy R Girgis, Mark Slifstein, Deepak D'Souza, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2024
Microglia-mediated neuroimmune suppression in PTSD is associated with anhedoniaRobin Bonomi, Ansel T Hillmer, Eric Woodcock, et al.
Epilepsia|September 18, 2020
Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [<sup>11</sup> C]UCB-J positron emission tomography studySjoerd J Finnema, Takuya Toyonaga, Kamil Detyniecki, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2024
Quantitative Accuracy Assessment of the NeuroEXPLORER for Diverse Imaging Applications: Moving Beyond Standard EvaluationsNegar Omidvari, Ekaterina Shanina, Edwin K Leung, et al.
Biological Psychiatry|October 12, 2024
Vitamin D's Capacity to Increase Amphetamine-Induced Dopamine Release in Healthy Humans: A Clinical Translational [<sup>11</sup>C]-PHNO Positron Emission Tomography StudyPatrick D Worhunsky, Marcella M Mignosa, Jean-Dominique Gallezot, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2009
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studiesIdriss Bennacef, Cristian A Salinas, Thomas A Bonasera, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2014
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformationAnn-Kathrin Eisfeld, Sebastian Schwind, Kevin W Hoag, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|October 11, 2017
Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging StudyChadi G Abdallah, Jonas Hannestad, Graeme F Mason, et al.
Pageof 92

Showing results (691-700 of 918) with videos related to

Sort By:
Pageof 92
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2016
Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A EnzymeLaigao Chen, Nabeel Nabulsi, Mika Naganawa, et al.
Annals of Neurology|December 14, 2011
Recovery from chronic spinal cord contusion after Nogo receptor interventionXingxing Wang, Philip Duffy, Aaron W McGee, et al.
Psychopharmacology|August 16, 2016
Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNORagy R Girgis, Mark Slifstein, Deepak D'Souza, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2024
Microglia-mediated neuroimmune suppression in PTSD is associated with anhedoniaRobin Bonomi, Ansel T Hillmer, Eric Woodcock, et al.
Epilepsia|September 18, 2020
Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [<sup>11</sup> C]UCB-J positron emission tomography studySjoerd J Finnema, Takuya Toyonaga, Kamil Detyniecki, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2024
Quantitative Accuracy Assessment of the NeuroEXPLORER for Diverse Imaging Applications: Moving Beyond Standard EvaluationsNegar Omidvari, Ekaterina Shanina, Edwin K Leung, et al.
Biological Psychiatry|October 12, 2024
Vitamin D's Capacity to Increase Amphetamine-Induced Dopamine Release in Healthy Humans: A Clinical Translational [<sup>11</sup>C]-PHNO Positron Emission Tomography StudyPatrick D Worhunsky, Marcella M Mignosa, Jean-Dominique Gallezot, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2009
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studiesIdriss Bennacef, Cristian A Salinas, Thomas A Bonasera, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2014
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformationAnn-Kathrin Eisfeld, Sebastian Schwind, Kevin W Hoag, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|October 11, 2017
Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging StudyChadi G Abdallah, Jonas Hannestad, Graeme F Mason, et al.
Pageof 92